Eric Dessertenne holds a pharmaceutical degree from the University of Clermont-Ferrand (France), an MBA from ESSEC Business School (Paris, France) and is a graduate of the Therapeutic Chair of Innovation at ESSEC Business School.

He began his career in the pharmaceutical industry working for Servier in France in the Corporate Strategy department and then moved to the Chinese subsidiary in Beijing, where he handled positions in the marketing and sales force department. Mr Dessertenne then joined LEK Consulting where he worked as a consultant in the Life Sciences and Private Equity practices.

In 2014, he brought his experience and insights on market opportunities to Biocorp as Head of Business Development & Commercial Operations, and was appointed Chief Operating Officer in 2016 and Chief Executive Officer in December 2019.

More contributions